Common Contracts
2 similar Trans-Pacific Partnership Agreement contracts
Trans-Pacific Partnership Agreement: Harmful provisions for access to medicinesTrans-Pacific Partnership Agreement • May 16th, 2014
The Trans-Pacific Partnership (TPP) is a proposed free trade agreement between 12 countries in the Asia-Pacific including the United States. According to leaked texts, the U.S. seeks to expand pharmaceutical monopolies at the expense of consumers’ health despite significant opposition from negotiation partners. In 2001, all World Trade Organization (WTO) members—including the U.S.—agreed that patent rights should not block access to affordable medicines and that IP rules should not interfere with countries’ public health agenda. In the TPP, however, the United States Trade Representative (USTR) is proposing measures that would limit generic competition, raise drug prices for consumers, and constrain future innovation in the Asia-Pacific. Almost all TPP countries oppose these proposals and some countries have heroically championed pro-competition and pro-health alternative measures. This chart provides an explanation of harmful provisions for access to medicines and their potential impa
Trans-Pacific Partnership Agreement: Harmful provisions for access to medicinesTrans-Pacific Partnership Agreement • January 17th, 2014
The Trans-Pacific Partnership (TPP) is a proposed free trade agreement between 12 countries in the Asia-Pacific including the United States. According to leaked texts, the U.S. seeks to expand pharmaceutical monopolies at the expense of consumers’ health despite significant. In 2001, all World Trade Organization (WTO) members—including the U.S.—agreed that patent rights should not block access to affordable medicines and that IP rules should not interfere with countries’ public health agenda. In the TPP, however, the United States Trade Representative (USTR) is proposing measures that would limit generic competition, raise drug prices for consumers, and constrain future innovation in the Asia-Pacific. Almost all TPP countries oppose these proposals and some countries have heroically championed pro-competition and pro-health alternative measures. This chart provides an explanation of harmful provisions for access to medicines and their potential impact. It also reflects country position
